Poster
MCLA-145 Increases T Cell Activation in Primary Immune Assays
Author
Patrick Mayes
Drug target
CD137 and PD-L1
Drug moa
Biclonics® T cell agonist that binds with high affinity and specificity to human PD-L1 and CD137
Source url
s3://convoke-optic-posters/2024-05-10/IC171-19E-AACR19-Mayes-MCLA-145-MoA-Poster_MT06_for-approval-032019.pdf
3 organizations
1 product
Product
MCLA-145Organization
Merus NV, Utrecht, The NetherlandsOrganization
Incyte Corporation, Wilmington, DEOrganization
University of Pennsylvania, Philadelphia, PA